Intercept Pharmaceuticals Inc
ICPT
Market Cap$0
Close$
$21.67
14% upside
Current Fair Value
14% upsideUndervalued by 14% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-98,858,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.48 |
| Beta | 0.0 |
| Outstanding Shares | 41,825,966 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 3.17 |
| Price to Book Ratio | 19.0 |
| Enterprise Value to Revenue | -0.34 |
| Enterprise Value to EBIT | 1.38 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -2.26 |
| Debt to Equity | 3.12 |
Revenue Sources
No data
ESG Score
No data